Welcome to the Sanofi Media Room

Our Media Room is designed to provide reporters with company and product news, as well as key facts, figures and background information.  To help you keep up with the latest news, we offer email alerts and RSS feeds.  If you are a reporter and have questions about the company or our products, visit the Media Contacts page.

Press Releases
Nov 15, 2021

Nexviazyme™ (avalglucosidase alfa for injection) is now approved in Canada for the long-term treatment of patients older than 6 months of age with late-onset Pompe disease (acid α-glucosidase...

Nov 10, 2021

In the news release, Canadians living with diabetes want increased mental health resources, are interested in taking a 360-approach towards holistic care, issued 10-Nov-2021 by Sanofi Canada over...

Oct 29, 2021

The approval is based on data from the open-label, multi-center, non-randomized Study 16201 MISSISSAUGA, ON, Oct. 29, 2021 /CNW/ - Libtayo® (cemiplimab) is now approved in Canada for the...

More »

Stay Updated
* Required Fields